Golden Finance reports that Nasdaq plans to delist BNB treasury company Windtree Therapeutics (stock code: WINT) due to the company's failure to comply with Nasdaq listing rule 5550(a)(2) — which requires the stock's minimum bidding price to remain above $1. Windtree confirmed its non-compliance status in documents submitted to the U.S. Securities and Exchange Commission.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Nasdaq plans to delist BNB treasury company Windtree Therapeutics for violations.
Golden Finance reports that Nasdaq plans to delist BNB treasury company Windtree Therapeutics (stock code: WINT) due to the company's failure to comply with Nasdaq listing rule 5550(a)(2) — which requires the stock's minimum bidding price to remain above $1. Windtree confirmed its non-compliance status in documents submitted to the U.S. Securities and Exchange Commission.